ZyVersa Therapeutics Inc (ZVSA)
3.76
+0.14
(+3.87%)
USD |
NASDAQ |
Jun 28, 16:00
3.71
-0.05
(-1.33%)
After-Hours: 20:00
ZyVersa Therapeutics Price to Book Value: 0.2797 for June 28, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 28, 2024 | 0.2797 |
| June 27, 2024 | 0.2693 |
| June 26, 2024 | 0.2782 |
| June 25, 2024 | 0.2641 |
| June 24, 2024 | 0.2812 |
| June 21, 2024 | 0.2991 |
| June 20, 2024 | 0.3593 |
| June 18, 2024 | 0.3757 |
| June 17, 2024 | 0.3906 |
| June 14, 2024 | 0.3906 |
| June 13, 2024 | 0.3629 |
| June 12, 2024 | 0.3548 |
| June 11, 2024 | 0.3353 |
| June 10, 2024 | 0.3444 |
| June 07, 2024 | 0.3281 |
| June 06, 2024 | 0.3534 |
| June 05, 2024 | 0.3645 |
| June 04, 2024 | 0.3504 |
| June 03, 2024 | 0.3615 |
| May 31, 2024 | 0.3675 |
| May 30, 2024 | 0.3035 |
| May 29, 2024 | 0.3174 |
| May 28, 2024 | 0.3164 |
| May 24, 2024 | 0.3206 |
| May 23, 2024 | 0.3191 |
| Date | Value |
|---|---|
| May 22, 2024 | 0.3281 |
| May 21, 2024 | 0.3273 |
| May 20, 2024 | 0.3124 |
| May 17, 2024 | 0.3338 |
| May 16, 2024 | 0.3615 |
| May 15, 2024 | 0.3675 |
| May 14, 2024 | 0.3935 |
| May 13, 2024 | 0.4062 |
| May 10, 2024 | 0.3995 |
| May 09, 2024 | 0.3928 |
| May 08, 2024 | 0.4166 |
| May 07, 2024 | 0.4813 |
| May 06, 2024 | 0.4754 |
| May 03, 2024 | 0.4054 |
| May 02, 2024 | 0.427 |
| May 01, 2024 | 0.3898 |
| April 30, 2024 | 0.3935 |
| April 29, 2024 | 0.4292 |
| April 26, 2024 | 0.3712 |
| April 25, 2024 | 0.4519 |
| April 24, 2024 | 0.4538 |
| April 23, 2024 | 0.4186 |
| April 22, 2024 | 0.4276 |
| April 19, 2024 | 0.4359 |
| April 18, 2024 | 0.4657 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.0472
Minimum
Apr 26 2023
0.5823
Maximum
Mar 18 2024
0.2449
Average
0.2216
Median
Price to Book Value Benchmarks
| OptiNose Inc | -- |
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | 19.93 |
| iBio Inc | 0.7319 |
| Theriva Biologics Inc | 0.1301 |
Price to Book Value Related Metrics
| Price | 3.76 |
| Earnings Yield | -46.89K% |
| Market Cap | 3.139M |